MEDEXUS PHARMACEUTICALS INC (MDP.CA) Stock Analyst Ratings
Canada - Toronto Stock Exchange - TSX:MDP - CA58410Q2036 - Common Stock
2.78 CAD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to MDP.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.3. This target is 126.7% above the current price.
MDP.CA was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDP.CA.
In the previous month the buy percentage consensus was at a similar level.
MDP.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-06 | RAYMOND JAMES LTD. | Upgrade | Outperform -> Strong Buy |
| 2025-01-06 | STIFEL CANADA | Maintains | Buy -> Buy |
| 2022-11-10 | Raymond James Capital | Upgrade | Outperform |
| 2022-10-07 | Canaccord Capital | Upgrade | Hold |
| 2022-09-22 | Canaccord Capital | Downgrade | |
| 2022-09-20 | Raymond James Capital | Downgrade | Market Perform |
| 2022-08-10 | Stifel Nicolaus Research | Downgrade | |
| 2022-07-26 | Raymond James Capital | Initiate | Outperform |
| 2022-03-02 | Raymond James Capital | Upgrade | Outperform |
| 2022-02-22 | Raymond James Capital | Initiate | Outperform |
| 2022-02-22 | Raymond James Financial | Initiate | Outperform |
| 2021-11-12 | NationalBankFinancial | Downgrade | Underperform |
| 2021-08-18 | Canaccord Genuity | Downgrade | Hold |
| 2021-03-02 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2021-02-17 | Canaccord Genuity | Upgrade | Speculative Buy |
MEDEXUS PHARMACEUTICALS INC / MDP.CA FAQ
What is the average price target for MEDEXUS PHARMACEUTICALS INC (MDP.CA) stock?
9 analysts have analysed MDP.CA and the average price target is 6.3 CAD. This implies a price increase of 126.7% is expected in the next year compared to the current price of 2.78.
How do analysts rate MEDEXUS PHARMACEUTICALS INC (MDP.CA)?
The consensus rating for MEDEXUS PHARMACEUTICALS INC (MDP.CA) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for MEDEXUS PHARMACEUTICALS INC stock?
The number of analysts covering MEDEXUS PHARMACEUTICALS INC (MDP.CA) is 9.